Abstract:

Orbital scintigraphy with ⁹⁹Tc^m-somatostatin analogue plays an important role in the diagnosis and treatment of patients with thyroid associated ophthalmopathy(TAO). It can be used to determine the orbital inflammatory activity, early diagnose the diseases, determine the need for treatment and select treatment options. At the same time, it also provides an important objective evidence for the evaluation of curative effect, prognosis prediction and related clinical research. Therefore, the application of orbital scintigraphy with ⁹⁹Tc^m-somatostatin analogue in TAO not only helps to standardize the diagnosis and treatment of the disease and obtain the best curative effect and prognosis, but also can effectively improve the overall level and efficiency of clinical diagnosis and treatment. (Ophthalmol CHN, 2016, 25: 361-364)

Key words: somatostatin analogues, orbital scintigraphy, thyroid associated ophthalmopathy